Latest Morning Briefing Stories
Medicare, Medicaid, preexisting conditions, high prescription drug costs: These buzz words are not likely to go away once the election-day dust settles. But what are the chances that the two chambers can find a common path forward. News outlets examine whether anything can get done in the wake of this split decision.
The health insurer allegedly used aggressive tactics to sell sham plans — one of which was named TrumpCare — that skirt the requirements of the Affordable Care Act, leaving people around the country with skimpier coverage than they expected and liable for unpaid medical bills. Also, more national news on Medicare Part B premiums and FDA’s approval of a new opioid.
The national issues in play also include Medicare-for-all, Medicaid expansion, marijuana legalization and soda taxes.
Democrats are hammering congressional Republicans who supported upending the Affordable Care Act, which guaranteed that people with medical problems could get coverage. GOP candidates and President Donald Trump vow that they would not take that away from patients, but they have not offered any plan.
A Los Angeles County Superior Court judge on Friday set a date for June 10 in the suit, known as Sanchez vs. CalPERS. It is expected to last three to four weeks.
A coalition of 40 large employers, including IBM, Verizon and American Express, will use an online tool from startup Rx Savings Solutions to help employees get better deals on prescriptions. Other pharmaceutical industry developments are reported out of Teva, Pfizer, Merck and McKesson. And in insurance news, Cigna reports strong third-quarter profits and boosts its 2018 forecast.
Analysts credit the improved coverage rates to the state’s implementation of the Affordable Care Act. Latinos are the only group that still shows a significant disparity to other ethnic groups. And, now that the health law marketplaces are open for business, news outlets detail what’s different this year and offer consumers advice.
In California, the ongoing vaccination debate is influencing the state Senate race in District 6. And the dialysis ballot initiative is being watched nationally.
In health policy developments from around the country: Seema Verma’s tweet; the Trump administration’s decisions related to changes to Wisconsin Medicaid; the Food and Drug Administration clears first genetic test for consumers; and migrant detention.
The insurer reports profits for the third quarter that were higher than predicted with total revenue of $23.25 billion. GlaxoSmithKline also offers a rosy earnings picture for the past quarter, with sales boosted by its new shingles vaccine.